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Abstract
Background: Integrase (IN) of the type 1 human immunodeficiency virus (HIV-1) catalyzes the integration of viral DNA into
host cellular DNA. We identified a bi-helix motif (residues 149–186) in the crystal structure of the catalytic core (CC) of the
IN-Phe185Lys variant that consists of the a4 and a5 helices connected by a 3 to 5-residue turn. The motif is embedded in a
large array of interactions that stabilize the monomer and the dimer.
Principal Findings: We describe the conformational and binding properties of the corresponding synthetic peptide. This
displays features of the protein motif structure thanks to the mutual intramolecular interactions of the a4 and a5 helices that
maintain the fold. The main properties are the binding to: 1- the processing-attachment site at the LTR (long terminal
repeat) ends of virus DNA with a Kd (dissociation constant) in the sub-micromolar range; 2- the whole IN enzyme; and 3- the
IN binding domain (IBD) but not the IBD-Asp366Asn variant of LEDGF (lens epidermal derived growth factor) lacking the
essential Asp366 residue. In our motif, in contrast to the conventional HTH (helix-turn-helix), it is the N terminal helix (a4)
which has the role of DNA recognition helix, while the C terminal helix (a5) would rather contribute to the motif stabilization
by interactions with the a4 helix.
Conclusion: The motif, termed HTHi (i, for inverted) emerges as a central piece of the IN structure and function. It could
therefore represent an attractive target in the search for inhibitors working at the DNA-IN, IN-IN and IN-LEDGF interfaces.
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Introduction
The integration of the HIV-1 genome into the host cell
chromosome is mediated by the viral integrase (IN) [1–6]. The
enzyme catalyzes a multi-step reaction i.e., 39-end processing and
strand transfer, to integrate a linear DNA copy (cDNA) of the
retroviral genome into the host cell DNA [2,7,8]. The retroviral
DNA integration mimics that of insertion elements and bacterio-
phage Mu transposons [9–11] and bears resemblance to the
RAG1/2 recombinase [12].
The HIV-1 IN is essential for the viral life cycle and is therefore
an attractive target for developing anti-HIV drugs [13,14]. The
enzyme (288 amino acid residues, 32 kDa) has three well defined
structural domains: an N terminal domain (residues 1 to 49), a
central catalytic domain or catalytic core, CC (residues 50 to 212),
and a C terminal domain (residues 213 to 288) [15–17]. Several
crystal structures of the CC domain and of two-domain fragments
(CC domain linked either to the C terminal domain or the N
terminal domain) have been already resolved by X-ray crystallog-
raphy [18–25] while the N terminal and C terminal domains have
been analyzed in solution by NMR [26,27]. Each domain, taken
separately, forms a dimer and this is true also true for the N
terminal-CC and the C terminal CC bi-domains [18–29]. The CC
dimer (Fig. 1a) is organized around a two fold axis with a large
interface involving, in particular, helices a1 and a5 (residues 172–
184) [18,30]. Other retroviral IN CC structures display the same
dimer boundary, indicating that this type of interface is
biologically relevant.
Actually, cross-linked dimers have been shown to be active for
39-processing and single end integration [31]. Yet, a large number
of data suggest that the tetramer is the form stabilizing the synaptic
complexes of IN with the two viral DNA ends and appears to be
the form required for the strand transfer [32–37]. Several
theoretical models of the DNA-IN complexes have proven the
relevance of tetramers to position the viral and cellular DNA
partners at reactive distance [38–41].
The CC domain is organized in five b-strands surrounded by six
a helices (a1 to a6), and contains a highly conserved catalytic D,
DX35E motif embedded in a protein RNase H fold [17,20,21].
The amphipathic a4 helix, (residues 148–167), which protrudes at
the protein surface, bears the catalytic residue Glu-152 and several
other residues, such as Gln-148, Lys-156 and Lys-159, which have
been shown to be important for the binding of IN to DNA and for
virus survival. In the crystal structure of CC bound to the inhibitor
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enol) among the six protein-drug interactions, five involve amino
acid side chains of the a4 helix [42], confirming the relevance of
the a4 helix to IN function [41,43–47].
The propensity of INto associateand form aggregatesis the main
barrier to the study of its structure and interactions by physical-
chemical means including the widely used x-rays and NMR
techniques. To date the only detailed depiction of the IN-DNA
complex is provided by molecular modeling [38–41]. To overcome
thedifficultiesinherenttothe useoftheentire enzymewedecided to
dissect its properties and to analyze it part by part. Our laboratory
has previously shown, in line with a systematic search by Li et al.
[48], that peptides deriving from the a4 helix had inhibitory activity
against IN [49,50]. This was also the case for peptides reproducing
the sequences of the a1 and a5 helices involved in the CC dimer
interface (a1:a59 and a19:a5) [30]. We have also shown that the
peptide region 163–171, encompassing both the turn and the N and
C terminal parts of the a4 and a5 helices, respectively, was a strong
epitope and antibodies refined against this region inhibited both the
39 processing and strand transfer reactions in in vitro assays [49].
Interestingly, the epitope region, in particular the residue Gln168
important for turn integrity, IN dimer formation and virus
replication, has been shown to share hydrogen bonds with the
IBD (IN binding domain) of LEDGF/p75 (lens epidermal derived
growth factor), a transcriptional coactivator that is also an essential
HIV integration cofactor in vivo [49,51–56]. Moreover, it has been
assumed that the peptide region 161–173 superposing our epitope
was involved in the nuclear import of IN [57], since a peptide
reproducing this sequence caused the active nuclear import of BSA
tethered toit[57,58];the matterwassomehowreassessedinsofaras
the fact that Val-165 and Arg-166 did not play the anticipated
specific roles in the nuclear localization of HIV-1 pre-integration
complex [59,60].
Actually, the a4 and a5 helices form a stable bi-helix fold at the
protein surface of the CC crystal structure (Fig.1a–f). This recalls
the well-known HTH (helix-turn-helix) motif of proteins special-
ized in DNA recognition [61]. Such motifs are generally associated
with biological functions, protein structures and even evolutionary
history. To assess the possible role of this bi-helix in IN we carried
out an analysis of the structural and binding properties of the
corresponding synthetic peptide (residues Gly-149 to Lys-186)
using circular dichroism (CD) [43] and fluorescence. The peptide
dealt with in this work represents the sequence found in the IN-CC
Phe185Lys variant (Table 1a). It has been logically preferred to the
native wt sequence (Table 1a) because it is the Phe185Lys variant
that was used in the various crystallizations [20] and co-
crystallizations so far reported [42,52]. The Phe185Lys mutation
is not expected to affect the interactions with LTR and LEDGF
IBD [51,52]. We have nevertheless performed a number of
experiments (not shown here) to verify that the structure of the wt
bi-helix was similar to that of the mutant.
Generally, the HTH motifs are strongly influenced by their
context within the proteins and often lose their original biological
functions when they are isolated from their protein environment.
Here, we show that the isolated HTH motif continues to fulfill
three of the major functions of the whole parental enzyme: i) it
recognizes the U5LTR extremity of viral DNA at the attachment-
processing site in a specific manner i.e., it preserves its viral DNA
binding property; ii) it self-associates and associates to IN i.e., it
reproduces some of the enzyme oligomerisation behavior, and iii)
it binds to the IBD of LEDGF but not to its Asp366Asn-IBD
variant lacking the essential Asp366 residue i.e., it maintains its
ability to interact with specific partners.
Results
The HTHi conformation
The bi-helix motif we focus on (a4 helix-turn-a5 helix) occurs in
the peptide segment from Gly-149 to Lys-186 of the IN-
Phe185Lys variant. Like many classical HTH motifs, this bi-helix
is exposed at the protein surface where it is largely accessible to
solvent, proteins, DNA and organic ligands (Fig. 1a) [20]. The two
helices are linked by a flexible turn of 3 to 5 residues bringing the
amphipathic a4 helix (situated in N terminal position) onto the C
terminal a5 helix through an angle of about 120u(Fig. 1b). The
helices interact with each other through 16 mainly hydrophobic
side chain–side chain contacts (Fig. 1c and Table 2). The
juxtaposition of the helices generates a positive electrostatic
potential exposed at the solvent accessible surface (Fig. 1d). The
only difference between the present motif and the standard HTH
motif is the inversion of position of the DNA recognition helix (a4
helix) and of the so-called stabilizing helix (a5) (Fig. 1e). Actually,
the bi-helix motif of IN resembles the RNA-recognizing motif of
Figure 1. Identification of an ‘‘inverted’’ HTH motif (HTHi) at
the catalytic core surface of integrase (PDB ID 1BIU [20]). a).
Crystal structure of the catalytic core domain, associated into a dimer.
b). Representation of the HTHi motif, with the loop residues shown by
van der Waals spheres. c). The side chain residues involved in
intramolecular contacts, shown by sticks and van der Waals spheres.
d). The electrostatic potential at the solvent-accessible surface; the Lys-
156, Lys-159 and Lys-160 residues are shown by sticks. e). HTHi motif of
IN, superimposed onto the ‘‘classical’’ HTH motif of the HMG (highly
mobile group) protein LEF-1 (lymphoid enhancer binding factor, PDB ID
2LEF, brown). f). HTHi motif of IN, superimposed onto the HTHi motif of
the Signal Recognition Particle (PDB ID 2FFH, green).
doi:10.1371/journal.pone.0004081.g001
Bi-Helix Motif of Integrase
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helices are inverted, the N terminal one recognizing the DNA and
the C-terminal one stabilizing the structure [62]. The bi-helix
motif was therefore hereafter called HTHi (helix-turn-helix
inverted).
The comparison of the GOR IV [63] and AGADIR [64]
predictions strongly suggest that long distance interactions–like
those stabilizing the protein tertiary structures–are needed besides
the short distance interactions in order to keep the helix secondary
structure in the HTHi motif (Fig. 2). Examination of the reported
crystal structures shows that long range interactions occur in great
number inside the HTHi motif itself i.e., between the a4 and the
a5 helices (there are 16 such interactions, listed in Table 2), but
also between the HTHi motif and other components of the protein
(for example, there are 16 interactions between HTHi and the
neighboring b-sheet–Table 2). Accordingly, a loss of helicity could
be feared upon isolation of the motif from the protein context.
CD analysis indicates that the secondary structure of the HTHi
peptide in solution is strongly concentration dependent. At 6 mM,
with its two negative bands at 208 nm and 222 nm, the CD
spectrum of HTHi reflects a helical content of 10–15% (full line
curve in Fig. 3). Upon increasing the peptide concentration to
25 mM, the CD spectrum manifests an important change. This is
illustrated by the reduction of the broad negative band at 222 nm,
Table 1. Sequences of Peptides and Oligonucleotides.
Peptides* wt HTHi SQG149VIESMNK156ELKKIIGQVRDQ168AEHLKTAVQMAVWIHNF185K
HTHi YG149VIESMNK156ELKKIIGQVRDQ168AEHLKTAVQMAVFIHNK185KA
a4 SQG149VVESMNK156ELKKIIGQVRY
K156 SQA149KLEEMNK156ELKKLLAQVRAQ168W
INH5 DQ168AEHLKTAVQMAVFIHNY185KA
Oligonucleotides ** LTR34 59-ACTGCTAGAGATTTTCCTTTGGAAAATCTCTAGCAGT-39
LTR34f59 59-fACTGCTAGAGATTTTCCTTTGGAAAATCTCTAGCAGT-39
LTR34fm 59-ACTGCTAGAGATTTTCCTFTGGAAAATCTCTAGCAGT-39
CRE 59-fGAGATGACGTCATCTC-39
*The HTHi peptide reproduces the Gly-149 to Lys-186 sequence of HIV-1 IN Phe185Lys [20]. The loop region is underlined. The mutated residues are in bold characters.
An N-terminal labeled carboxyfluorescein derivative of HTHi was also used (not shown). The peptides a4, K156 and INH5 were dealt with in [30,43,50].
**The LTR34 oligonucleotides are designed to adopt a hairpin conformation, as already reported [43]. The hairpins contain a 17 bp stem, reproducing the HIV-1 U5LTR
end, and a loop formed by three thymine nucleotides (TTT in bold characters). The fluorescein reporter group, f, is grafted either to the 59 extremity (LTR34f59, CRE) or
to the central T residue (F) of the loop (LTR34fm).
doi:10.1371/journal.pone.0004081.t001
Table 2. Main interactions within HTHi (helices a4 and a5) and of HTHi with the neighbouring b-sheet in the IN catalytic core (data
from PDB ID 1BIU, [20]).
a4-helix b-sheet
V150 I151 M154 N155 E157 L158 I161 I162 V165 R166 Q168 Y83 I84 A86 V88
L172 WW
A175 WW
V176 WW W
Q177 H
M178 WW
a5-helix A179 WW W
V180 WW
I182 WW
H183 E W
N184 WW
I186 E
Q62 WW
N64 W E/H
b-sheet L68 W
I73 W
V75 WW
I84 WW
w: hydrophobic contacts; H: hydrogen bonds; E: Electrostatic interactions.
doi:10.1371/journal.pone.0004081.t002
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larger band mostly centered at 198 nm that bears a component
with positive tendency at 190 nm, signaling the presence of a weak
amount of helix (dotted line curve in Fig. 3).
The above CD experiments reveal the propensity of HTHi to
form oligomers in solution at high concentration. It appears that
the setting up of intermolecular interactions occurs at the
detriment of the intramolecular interactions between the a4 and
the a5 helices and impairs the stability of the HTHi fold and
consequently that of the of the helix secondary structure. We argue
that the weakening of these intramolecular interactions is the main
cause leading to a decrease of the helix content of the motif at high
peptide concentration.
The stabilization of the HTHi fold by the intramolecular
interactions between the a4 and a5 helices is highlighted by the
comparison of the CD spectrum of HTHi with the spectra of its
component peptides, a4 and INH5 (inset to Figure 3). The fact
that the helix content of HTHi is greater than that of peptides a4
[43] and INH5 [30] is particularly obvious in the low-wavelength
region of the CD spectra. Indeed, while the separate components
of the bi-helix show important negative bands in the 195 nm
domain of the spectrum, this feature vanishes in the spectrum of
HTHi, which develops a positive band below 190 nm, compatible
with a helical structure.
Binding of the HTHi motif to viral DNA
We carried out CD and fluorescence experiments to demon-
strate that peptide HTHi binds with a good affinity to the viral
LTR DNA.
To begin with, CD was used to assess the conformational
changes undergone by the HTHi peptide upon interacting with
LTR34 DNA (Table 1). Indeed, the latter exerts a helix stabilizing
effect that is attested in the difference spectrum (i.e., peptide-DNA
complex minus DNA) by the increase of the positive band at
190 nm and of the two negative bands at 208 and 222 nm, less
perceptible in the spectra of unbound HTHi (Fig. 3). The HTHi
motif practically doubles its helical content when binding to
LTR34. This behavior is not unique: we have already shown that
a peptide derived from the b-ZIP (basic-zipper) motif of the c-jun
protein manifested the same helix stabilization upon binding to
DNA [65].
The binding parameters were determined by fluorescence
anisotropy measurements. A representative binding isotherm
illustrating the titration of the oligonucleotide LTR34fm
(Table 1b), by peptide HTHi is shown in Fig. 4a. The binding
curve is biphasic, whereas that obtained with the structural analog
LTR34f59 is monophasic. With LTR34fm, each plateau indicates
the saturation of an interaction. The first, corresponding to the
high affinity binding, has been assigned to the specific recognition
by HTHi of the extremity of viral DNA [43]. The high affinity is
abolished by the grafting of the fluorescein moiety at the
59extremity (LTR34f59) (Fig. 4a). The dissociation constants of
peptide HTHi, determined by curve fitting, are Kd1=0.05 mM
and Kd2=1.9 mM for LTR34fm and Kd=2.9 mM for LTR34f59
(Fig. 4a). Note that the non-specific binding to the negative control
sequence (CRE, cAMP response element) is within this latter range
of affinities (Kd=6.6 mM).
Interaction of the HTHi motif with wt IN
In a previous study, based on the intrinsic fluorescence
properties of IN conferred by its six Trp residues, we have shown
the ability of peptide INH5 (Table 1a) to interact with IN with a
concentration midpoint (C0.5) of 168 nM [30]. The interaction,
occurring at the a19:a5/a1:a59 interface, caused the dissociation of
the tetramers and dimers of IN [30]. The experiments performed
with HTHi under conditions similar to those we had previously
used for peptide INH5 [30], show that HTHi interacts with wt IN
(at 100 nM monomer concentration) with a C0.5 value of 104 nM,
while the peptide a4, taken alone, binds to wt IN with a C0.5 value
of 53 nM (Fig. 3b). Indeed, we had previously shown that peptide
a4 interacted with IN likely by forming a coiled-coil structure with
its counterpart in the protein [50,66].
Interaction of the HTHi motif with LEDGF
Fluorescence anisotropy was also used to asses the binding of the
HTHi motif to IBD-LEDGF. A fluorescein-labeled HTHi peptide
(Fig. 4c) was prepared for this purpose and titrated by both the wt
and the Asp366Asn mutated LEDGF IBD protein ligands. It has
been previously shown that Asp366 is essential for the binding of
LEDGF to IN [52,54]. The overall pattern unambiguously shows
that only the wt IBD binds HTHi. Curve analysis provides a Kd of
the order of 12 mM. We find that HTHi reproduces the properties
of the CC of IN in so far as the recognition of LEDGF is
Figure 2. Secondary structure predictions. Results provided by: a).
Agadir [64] and b). GOR IV [63] for the helical propensities of HTHi
(blue), a4 (green) and INH5 (orange). The predictions with Agadir were
performed at pH 7, at a temperature of 25uC.
doi:10.1371/journal.pone.0004081.g002
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interaction is confirmed.
Discussion
The so-called HTHi motif (a4-turn-a5) identified at the IN
protein surface presents an unexpected multiplicity of functions
revealed by the study of the corresponding synthetic HTHi
peptide. In the latter, hydrophobic contacts between its a4 and a5
arms confer stability to the ensemble, i.e., to the tertiary structure
and the helical secondary structure. The a4 helix is more basic
than the a5 helix, which is consistent with its DNA binding
property. However, only a stable preformed scaffold permits the
proper spatial orientation of the interactive amino acid side chains
and their adjustment onto their complementary nucleotides of the
DNA target without large conformational change and therefore
large consumption of energy. This improves the affinity and
confers specificity to the binding.
Our results strongly suggest that helix stability in the HTHi
motif is essential to the specific recognition of viral DNA. In
particular, the a4 peptide taken in isolation, which does not benefit
of the HTHi stabilizing context, is a very poor DNA binder. The
difference of DNA binding affinity between the peptides HTHi
and a4 can be attributed to the larger conformational change that
the latter must undergo in order to adopt the bound helical
conformation.
In a previous work we pointed out the importance of the
conformational entropy in the binding of the a4 helix to the viral
DNA. In order to reduce this effect, we had designed an analog of
the a4 peptide that had its secondary structure stabilized by
helicogenic mutations (Gly149Ala, Ile161Leu, Ile162Leu and
Gly163Ala). The resulting peptide, K156, was a good mimic of
the a4 helix in the protein context and was better organized for
binding than peptide a4. The use of peptide K156 with the
oligonucleotide LTR34fm permitted the identification of a high
affinity site (Kd1=2.1 nM), corresponding to the attachment site
of the enzyme on the six outermost bases of viral DNA and of a
low affinity site in the micromolar range (Kd2=54mM) corre-
sponding to the non-specific binding of IN[43]. The grafting of the
bulky fluorescein at the 59 extremity (LTR34f5; Table 1b), i.e., at a
position in close proximity to the 39-processing site, suppressed the
high affinity binding mode of K156 but preserved the low affinity
mode. The absence of effect on the binding to the low affinity site
from the grafted fluorescein suggested that this site was distant on
the DNA from the high affinity site [43].
The behavior of peptide HTHi is similar to that of peptide
K156. With HTHi there are two binding modes as well, one with
a low dissociation constant in the nanomolar range ( Kd1=50 nM)
and the other with a high dissociation constant in the micromolar
range ( Kd2=1.9 mM ), in the case of LTR34fm; and there is only
one binding mode in the micromolecular range (Kd=2.9 mM)i n
the case of LTR34f59 (Fig. 4a). The non-specific binding of peptide
HTHi to the negative control sequence, CRE, is within this latter
range of affinities; Kd=6.6 mM. ; comparatively, that of peptide
K156 was 16 mM [43].
Thus, the two peptide ligands, HTHi and K156, present the
same DNA binding properties. The two binding modes, of which
the first appears specific for the intact processing-attachment site of
LTR DNA, are present in the two cases, albeit with different
affinities. The role of conformation is noteworthy. Peptide K156,
whose secondary structure has largely benefited from helicogenic
mutations, manifests a greater affinity for viral DNA than peptide
HTHi, in which the a4 helix component, certainly stabilized by its
interactions with the a5 helix, is nevertheless less stable than
Figure 3. Circular dichroism. Spectra of peptide HTHi at 6 mM(
__, red) and at 25 mM (—, black), and difference spectrum of the complex [HTHi
(6 mM)+LTR34 (10 mM)] minus the CD spectrum of LTR34 (10 mM) (…….., blue). Insert: CD spectrum of HTHi compared to the spectra of its
component peptides, a4 (after Figure 6 in [43]) and INH5 (after Figure 3b in [30]). Recall that INH5 comprises both the a5 helix and the turn linking a5
to a4 (Table 1a).
doi:10.1371/journal.pone.0004081.g003
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formed conformation for binding of peptide K156 compared with
peptide HTHi that lowers the entropy cost of interaction of the
former. As a corollary, the isolated peptide a4, which mostly
displays random conformation because of the absence of either
helicogenic mutations in its sequence or helix stabilization
conferred by the interaction with a5, is completely unable to
specifically bind the viral DNA.
X-ray crystallographic studies of the co-crystal of CC with
5CITEP also illustrate the importance of the HTHi a4 helix in the
IN enzyme. Results strongly suggest that the a4 helix would be the
primary target of the DKA (diketo acid/aryl) family of inhibitors of
IN acting on the 39 processing step [14,42,67]. In the complex, the
drug interacts with five residues of the a4 helix and at least four of
them (Lys-156, Lys-159, Gln-148 and Glu-152) are also implicated
in the stabilization of the viral DNA-CC complex [14,43].
Concerning the role of the a5 helix, it is clear from the various
crystal structures that it participates to both the dimerization of the
enzyme and the stabilization of the motif [18–29]. There are
examples in the literature showing that the so-called stabilizing
helix of HTH motifs is involved in the protein dimerization. This
is the case of topoisomerase II, in which the binding site to DNA is
fashioned from the interaction of two HTH motifs [68]. The
implication of the a5 helix in the enzyme structure and activity has
been highlighted in our previous report showing that peptide
INH5, which comprises the a5 helix, inhibits IN by dissociating
the IN dimers and tetramers [30].
The role of the HTHi motif is not limited to that of its a4 and a5
helix components. At the solvent accessible surface, in the center of
the motif, the electrostatic potential is uniform and positive and it
changes sign at the turn connecting the a4 and a5 helices (Fig. 1d).
The 161–173 region is a strong epitope and also a protein binder
[49,51–56]. Antibodies enriched against this epitope inhibit both
the 39 processing and the strand transfer reaction [49]. The
particular variation of the electrostatic potential at the solvent
accessible surface in that region is compatible with these functions.
As a matter of fact, a peptide corresponding to the epitope region
has been shown to mediate the nuclear import of the covalently
linked serum albumin [58], although this region has been
incorrectly proposed as being a possible NLS (nuclear localization
signal) [57]. Nevertheless, the present results confirm the
propensity of the epitope region to associate with important
proteins, such as LEDGF. The co-crystal structure of CC bound to
LEDGF-IBD shows that the epitope region is recognized by
LEDGF. The formation of a complex between IN and LEDGF is
biologically relevant and is a prerequisite to the strand transfer into
the cell chromosome [51–56]. In the complex, there are numerous
stabilizing contacts, such as those involving the a3 helix and a
portion of the a1 helix, but it is the turn region of HTHi ( residues
Glu-170, His-171 and Gln-168 ) that makes the major contribu-
tion, particularly in binding the hotspot residue Asp-366 and the
residue Ile-365 of LEDGF[51,52,54]. Our results are compatible
with these findings. Resembling the IN CC, the peptide HTHi
binds wt IBD, but not its Asp366Asn variant. We are thus allowed
to conclude that the pattern of interactions found in the CC-IBD
crystal is still present in the peptide HTHi-IBD complex.
All together, the results mentioned above indicate that the
HTHi motif identified in IN behaves like a multifunctional entity.
Being involved in enzyme oligomerisation (via its a5 helix), in LTR
end recognition (via its a4 helix) and in binding to LEDGF (via the
turn region, which also acts as a strong epitope), it emerges as a
central piece of both the IN structure and activity. Moreover, the
a4 helix of HTHi could be the target of inhibitors belonging to the
DKA family, as suggested by the crystal structure of 5 CITEP
Figure 4. Fluorescence. a). Interaction with DNA. Fluorescence
anisotropy titration by peptide HTHi of LTR34fm (squares, red) and
LTR34f59 (triangles, blue). Inset: titration of CRE by peptide HTHi. In all
cases, the fluorescein-labeled DNA was at 20 nM. The Kd values
obtained by curve fitting (with 610% uncertainty) are: 0.05 mM and
1.9 mM for LTR34fm; 2.9 mM for LTR34f59; and 6.6 mM for CRE. b).
Interaction with wt IN. Quenching of the intrinsic fluorescence of wt
IN by peptide HTHi. Inset: Titration of wt IN by peptide a4. In all cases,
the wt IN monomer concentration was 100 nM. The midpoints of the
titration curves are at 10468 nM and 5365 nM for peptides HTHi and
a4 respectively. c). Interaction with LEDGF-IBD. Fluorescence
anisotropy titration of fluorescein-grafted HTHi peptide (50 nM) by
LEDGF-IBD (wt IBD, round symbols, and mutated IBD, squares). The Kd
of the wt IBD-HTHi interaction is 12.360.3 mM, with a Hill number of
1163.
doi:10.1371/journal.pone.0004081.g004
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constitute a reliable model for the study of new inhibitors acting at
the IN-IN, the IN-DNA and the IN-LEDGF interfaces. This issue
will be further addressed possibly by looking for peptidomimetics
to the a4 and a5 helices, as well as to the epitope region–with the
aim of transforming them into therapeutic agents.
Materials and Methods
Peptides
We used the synthetic peptides shown in Table 1a. They were
made according to the Fmoc procedure, as already reported for
peptide a4, for its ‘‘stabilized’’ analogue i.e., peptide K156, and for
the peptide INH5, derived from the a5 helix [30,43]. Peptide a4
reproduces the a4 helix sequence of IN; peptide K156 is a variant
of the a4 peptide resulting from the replacement of weakly
helicogenic residues by more helicogenic ones in several
biologically irrelevant positions [43]; peptide INH5 contains both
the a5 helix and the turn connecting the a5 helix to the a4 helix
[30]. The peptides HTHi and wt HTHi reproduce the sequences
of the HTHi motifs in the IN-Phe185Lys variant and in wt IN
respectively. A version of the HTHi peptide with a carboxyfluor-
escein at the N-terminus has also been prepared. Tyr or Trp
aromatic residues, when absent in the native sequences, were
purposely added in order to enable peptide quantification by UV
absorption spectra. Peptide concentrations were determined using
a molar absorption coefficient at 280 nm equal to
1 280 M
21 cm
21 for the tyrosine-containing peptides a4, INH5
and HTHi and 5600 M
21 cm
21 for the tryptophane-containing
peptides K156 and wt IN.
DNA oligonucleotides
The oligonucleotides (Table 1b) were purchased from Cyber-
gene ESGS (France) and Eurogentec (Belgium). The choice of
monomolecular hairpin-forming oligonucleotides, rather than
bimolecular duplex-forming ones, was motivated by the need for
stability under the low concentrations inherent to the fluorescence
anisotropy experiments. The fluorescein reporter group is grafted
either to the central T nucleotide (LTR34fm) or to the 59
extremity (LTR34f59 and CRE). The CRE (cAMP responsive
element) sequence was used as negative control. The version of
LTR34 without fluorescein was used in CD studies.
Proteins
Fluorescence titrations were performed with the wild-type IN
(wt IN) [69]. The presence of Trp in the enzyme (IN contains six
Trp residues) but not in the peptides, was exploited when
performing intrinsic fluorescence quenching titrations of the
former. The wt IBD is the fragment 347–471 of LEDGF (GST
removed) [33,51,52]. The mutant IBD is the Asp366Asn version of
the former. Like the whole protein, these contain no Trp. The
concentrations of wt IN (33.781 kDa) and of the IBD fragments
(16.542 kDa) were estimated from UV absorption at 280 nm,
using the molar absorptivities of 46542 M
21 cm
21 and
1400 M
21 cm
21 respectively. The proteins were used in the
‘‘reaction buffer’’ containing 20 mM HEPES (pH 6.8), 10 mM
MgCl2 and 10 mM DTT.
Secondary structure predictions
Secondary structure predictions were carried out using the
AGADIR and GOR IV computer programs available on the web
respectively at http://www.embl-heidelberg.de/serices/serrona/
agadir-start.html and http://pbil.univ-lyon1.fr/ (Po ˆle Bioinforma-
tique Lyonnais, France) [63,64]. The AGADIR prediction
considers short range interactions between residues and provides
helical propensity per residue of peptides in solution, indepen-
dently of tertiary structure interactions, with the possibility of
selecting the pH and the temperature conditions. GOR IV uses
parameters derived from crystallographic data of proteins. It thus
provides more realistic structure predictions for peptide segments
submitted to tertiary and quaternary structures constraints i.e.,
within the protein environment. Thus the two types of predictions
can be used in conjunction to find the impact of the protein
context on the secondary structure of its peptide elements, to
identify the effect of mutations on secondary structures and to
select the mutations that would reinforce the helicity of peptides, as
was done in the case of peptide K156 (Table 1a) [43].
CD Spectroscopy
CD spectra were recorded on a Jobin-Yvon CD6 dichrograph
(HORIBA Jobin-Yvon, France). Peptide concentrations varied
from 5 to 25 mM in the ‘‘assay buffer’’, containing 40 mM sodium
phosphate, 0.5 mM EDTA, pH 6.0. The samples, incubated
10 min at the chosen temperature to allow the solutions to reach
their equilibrium state, were placed in thermally jacketed cells with
a 1 mm path length. The spectra, recorded in 1 nm steps, were
averaged over ten scans and corrected for the base line, then
presented as differential molar absorptivities per residue, De
(M
21 cm
21), for peptides, and as difference spectra (complex
minus DNA), for peptide-DNA complexes. For the HTHi-LTR
interaction, aliquots of peptide were added to LTR34 (10 mM) and
the control spectrum of unliganded LTR was subtracted from that
of the complex. Recall that in a simple random coil – a helix
equilibrium, the a-helix content of peptides could be approximat-
ed by the relation: Pa=2[De222610] (Pa: percentage of a helix;
De222: differential molar absorptivity per residue at 222 nm) [70].
Modeling
We used the Insight IIH program (Accelrys Software Inc., CA,
USA) to estimate distances between the various atoms in HTHi
and between HTHi and the b-stands located in the proximity,
using the CC IN crystal structure (PDB ID 1BIU) [20] (Fig. 1 and
Table 2). Graphics was by PyMol (http://www.pymol.org) [71]
with the APBS software (http://apbs.sourceforge.net/) [72].
Fluorescence Measurements
Intrinsic fluorescence quantum yield and fluorescence anisotro-
py studies were carried out with a Jobin-Yvon Fluoromax II
instrument (HORIBA Jobin-Yvon, France) equipped with an
ozone-free 150 W xenon lamp. The samples (800 ml) were placed
at 5uC in thermally jacketed 1 cm60.5 cm quartz cells. At least
ten measurements for each titration point were recorded with an
integration time of 5 sec.
The intrinsic fluorescence [73] of wt IN was measured at 100 nM
monomer concentration, in the ‘‘reaction buffer’’ (see above). The
Trp residues were excited at 295 nm and emission was recorded
between 305 and 450 nm, with 2 nm and 5 nm excitation and
emission slit widths, respectively. A maximal emission was
obtained at 337 nm. Quenching of the fluorescence of IN
following the addition of HTHi or of peptide a4 (devoid of Trp)
was expressed as 1-F/F0, where F0 is the fluorescence of the
enzyme in the absence of peptide.
Fluorescence anisotropy titration [74,75]. Fluorescein-labeled oligo-
nucleotides were used at 20 nM in the ‘‘assay buffer’’ (see Table 1b
and above). With fluorescein as fluorophore, excitation and
emission were at 488 nm and 516 nm, with 4 nm and 5 nm slits,
respectively. Peptides were added to DNA as successive aliquots.
For each anisotropy measurement, the parallel I‘
  
and the
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buffer and protein contributions) were subtracted from those of the
sample.
The fluorescence anisotropy of the fluorescein-conjugated
version of HTHi (50 nM) titrated by wt and mutated IBD in the
‘‘assay buffer’’ was used to evaluate the Kd of the LEDGF-HTHi
complex.
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